Breaking News
Get 50% Off 0
🧩 Based on my current watchlist, how should I diversify my portfolio?
Ask WarrenAI
Close

Novogene Co Ltd (688315)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
16.08 -0.23    -1.41%
08/08 - Closed. Currency in CNY
Type:  Equity
Market:  China
ISIN:  CNE1000052X3 
  • Volume: 5,530,111
  • Bid/Ask: 16.08 / 16.09
  • Day's Range: 16.00 - 16.49
Novogene Co 16.08 -0.23 -1.41%

Novogene Co Ltd Company Profile

 
Get an in-depth profile of Novogene Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

2144

Equity Type

ORD

Novogene Co., Ltd., together with its subsidiaries, provides genomic services and solutions in Mainland China, Hong Kong, Macau, Taiwan, and internationally. The company offers genomic solutions comprising human, animal, plant, and microbial whole genome sequencing, as well as human and mouse whole exome sequencing, microbial de novo sequencing, animal and plant de novo sequencing, and 12S/18S/ITS amplicon and shotgun metagenomic sequencing; transcriptomics solutions, such as mRNA, long non-coding RNA, small RNA, circular RNA, whole transcriptome, isoform, direct RNA, prokaryotic RNA, and metatranscriptome sequencing; and single cell gene expression, single cell long road read transcriptome, and visium formalin-fixed paraffin-embedded spatial transcriptome solutions. It also provides epigenomic solutions comprising whole genome bisulfite, reduced representation bisulfite, chromatin immunoprecipitation, and RNA immunoprecipitation sequencing; premade library and proteomics services; clinical diagnostics services, such as clinical whole exome sequencing and clinical panels; biopharma services consisting of discovery and pre-clinical, translational and clinical, and companion diagnostics; and support services. In addition, the company offers sequencing platforms under the ILLUMINA, PACBIO, 10X GENOMICS, and NANOPORE brands; and basic scientific research services in life sciences, and medical research and technical services. Its services are used in cancer research, immuno-oncology agrigenomics, environment, food science, human microbiome, plant and animal microbiome, drug discovery and development, and rare and complex diseases applications. The company serves research universities, research institutes, hospitals, pharmaceutical research and development companies, and agricultural companies. Novogene Co., Ltd. was founded in 2011 and is headquartered in Beijing, China.

Contact Information

Address Building 301 Room 101
No. 10, Jiuxianqiao North Road Chaoyang District Beijing,100015
China
Phone 86 10 8283 7801
Fax 86 10 8283 7867

Top Executives

Name Age Since Title
Ruiqiang Li 45 2019 Founder, Chairman of the Board & CEO
Chunfei Wang 45 2022 Independent Director
Nijia Feng 30 2022 Supervisor
Quan Gan 49 2022 Director
Ping Li 45 2022 Supervisor
Tianfan Wang 42 2023 Independent Director
Qifeng Wang 46 2019 Deputy GM, Secretary of the Board of Directors & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

688315 Comments

Write your thoughts about Novogene Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email